WAP domain proteins as modulators of mucosal immunity

Biochemical Society Transactions

Volumn 39, Issue 5, 2011, Pages 1409-1415

  Wilkinson, Thomas S ^a   Roghanian, Ali ^b   Simpson, Alexander John ^c   Sallenave, Jean Michel ^d,e,f  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d INSTITUT PASTEUR   (France)

^e INSERM   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Antiprotease activity; Elafin; Mucosa; Neutrophil; Opsonization; Trappin 2

Indexed keywords

B7 ANTIGEN; CATHEPSIN G; CD86 ANTIGEN; CHYMOTRYPSIN; DEXAMETHASONE; ELAFIN; FLUTICASONE; GAMMA INTERFERON; HYDROCORTISONE; I KAPPA B; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOMODULATING AGENT; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN 12; INTERLEUKIN 1BETA; LEUKOCYTE ELASTASE; LIPOCORTIN 2; LIPOPOLYSACCHARIDE; METHYLPREDNISOLONE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOBLASTIN; PROTEIN C JUN; SCRAMBLASE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRIAMCINOLONE; TRYPSIN; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTHRITIS; ASTHMA; BACTERIAL OPSONIZATION; CELL MEMBRANE; CONFERENCE PAPER; CONJUNCTIVITIS; CRYSTAL STRUCTURE; CYTOKINE PRODUCTION; DENDRITIC CELL; DNA BINDING; DRUG DISTRIBUTION; ENZYME ACTIVITY; ENZYME REGULATION; EXON; GAMMA DELTA T LYMPHOCYTE; HUMAN; IMMUNOMODULATION; INFLAMMATION; ISCHEMIA REPERFUSION INJURY; MUCOSAL IMMUNITY; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN INTERACTION; PROTEIN TARGETING; REPERFUSION INJURY; TH1 CELL; TISSUE INJURY; TISSUE REPAIR; WOUND HEALING IMPAIRMENT;

ANIMALS; ELAFIN; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATION; MILK PROTEINS; PROTEASE INHIBITORS; PROTEIN STRUCTURE, TERTIARY; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; TISSUE DISTRIBUTION;

BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 80053349471     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0391409     Document Type: Conference Paper

References (104)

1. Fritz, H. (1988) Human mucus proteinase inhibitor (human MPI): human seminal inhibitor I (HUSI-I), antileukoprotease (ALP), secretory leukocyte protease inhibitor (SLPI). Biol. Chem. Hoppe Seyler 369 (Suppl), 79-82
2. Stetler, G., Brewer, M.T. and Thompson, R.C. (1986) Isolation and sequence of a human gene encoding a potent inhibitor of leukocyte proteases. Nucleic Acids Res. 14, 7883-7896
3. Kikuchi, T., Abe, T., Hoshi, S., Matsubara, N., Tominaga, Y., Satoh, K. and Nukiwa, T. (1998) Structure of the murine secretory leukoprotease inhibitor (SLPI) gene and chromosomal localization of the human and murine SLPI genes. Am. J. Respir. Cell Mol. Biol. 19, 875-880 (Pubitemid 128354285)
4. Grutter, M.G., Fendrich, G., Huber, R. and Bode, W. (1988) The 2.5 ÅX-ray crystal structure of the acid-stable proteinase inhibitor from human mucous secretions analysed in its complex with bovine á- chymotrypsin. EMBO J. 7, 345-351
5. Campbell, S.M., Rosen, J.M., Hennighausen, L.G., Strech-Jurk, U. and Sippel, A.E. (1984) Comparison of the whey acidic protein genes of the rat and mouse. Nucleic Acids Res. 12, 8685-8697
6. Kramps, J.A., van Twisk, C., Appelhans, H., Meckelein, B., Nikiforov, T. and Dijkman, J.H. (1990) Proteinase inhibitory activities of antileukoprotease are represented by its second COOH-terminal domain. Biochim. Biophys. Acta 1038, 178-185 (Pubitemid 20135862)
7. Eisenberg, S.P., Hale, K.K., Heimdal, P. and Thompson, R.C. (1990) Location of the protease-inhibitory region of secretory leukocyte protease inhibitor. J. Biol. Chem. 265, 7976-7981
8. 107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation. Br. J. Pharmacol. 108, 1100-1106
9. Ding, A., Thieblemont, N., Zhu, J., Jin, F., Zhang, J. and Wright, S. (1999) Secretory leukocyte protease inhibitor interferes with uptake of lipopolysaccharide by macrophages. Infect. Immun. 67, 4485-4489 (Pubitemid 29400423)
10. Gomez, S.A., Arguelles, C.L., Guerrieri, D., Tateosian, N.L., Amiano, N.O., Slimovich, R., Maffia, P.C., Abbate, E., Musella, R.M., Garcia, V.E. and Chuluyan, H.E. (2009) Secretory leukocyte protease inhibitor: a secreted pattern recognition receptor for mycobacteria. Am. J. Respir. Crit. Care Med. 179, 247-253
11. Fath, M.A., Wu, X., Hileman, R.E., Linhardt, R.J., Kashem, M.A., Nelson, R.M., Wright, C.D. and Abraham, W.M. (1998) Interaction of secretory leukocyte protease inhibitor with heparin inhibits proteases involved in asthma. J. Biol. Chem. 273, 13563-13569 (Pubitemid 28268398)
12. Ying, Q.L., Kemme, M., Saunders, D. and Simon, S.R. (1997) Glycosaminoglycans regulate elastase inhibition by oxidized secretory leukoprotease inhibitor. Am. J. Physiol. 272, L533-L541
13. Hirano, M., Kamada, M., Maegawa, M., Gima, H. and Aono, T. (1999) Binding of human secretory leukocyte protease inhibitor in uterine cervical mucus to immunoglobulins: pathophysiology in immunologic infertility and local immune defense. Fertil. Steril. 71, 1108-1114 (Pubitemid 29252505)
14. Taggart, C.C., Greene, C.M., McElvaney, N.G. and O'Neill, S. (2002) Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IκBα degradation without affecting phosphorylation or ubiquitination. J. Biol. Chem. 277, 33648-33653
15. Lentsch, A.B., Jordan, J.A., Czermak, B.J., Diehl, K.M., Younkin, E.M., Sarma, V. and Ward, P.A. (1999) Inhibition of NF-κB activation and augmentation of IκBα by secretory leukocyte protease inhibitor during lung inflammation. Am. J. Pathol. 154, 239-247 (Pubitemid 29031631)
16. Ma, G., Greenwell-Wild, T., Lei, K., Jin, W., Swisher, J., Hardegen, N., Wild, C.T. and Wahl, S.M. (2004) Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection. J. Exp. Med. 200, 1337-1346 (Pubitemid 39552574)
17. Tseng, C.C. and Tseng, C.P. (2000) Identification of a novel secretory leukocyte protease inhibitor-binding protein involved in membrane phospholipid movement. FEBS Lett. 475, 232-236
18. Py, B., Basmaciogullari, S., Bouchet, J., Zarka, M., Moura, I.C., Benhamou, M., Monteiro, R.C., Hocini, H., Madrid, R. and Benichou, S. (2009) The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane. PLoS ONE 4, e5006
19. Franken, C., Meijer, C.J. and Dijkman, J.H. (1989) Tissue distribution of antileukoprotease and lysozyme in humans. J. Histochem. Cytochem. 37, 493-498 (Pubitemid 19086846)
20. Fryksmark, U., Ohlsson, K., Polling, A. and Tegner, H. (1982) Distribution of antileukoprotease in upper respiratory mucosa. Ann. Otol. Rhinol. Laryngol. 91, 268-271 (Pubitemid 12081826)
21. De Water, R., Willems, L.N., van Muijen, G.N., Franken, C., Fransen, J.A., Dijkman, J.H. and Kramps, J.A. (1986) Ultrastructural localization of bronchial antileukoprotease in central and peripheral human airways by a gold-labeling technique using monoclonal antibodies. Am. Rev. Respir. Dis. 133, 882-890 (Pubitemid 16116520)
22. Kouchi, I., Yasuoka, S., Ueda, Y. and Ogura, T. (1993) Analysis of secretory leukocyte protease inhibitor (SLPI) in bronchial secretions from patients with hypersecretory respiratory diseases. Tokushima J. Exp. Med. 40, 95-107
23. Ohlsson, K., Sveger, T. and Svenningsen, N. (1992) Protease inhibitors in bronchoalveolar lavage fluid from neonates with special reference to secretory leukocyte protease inhibitor. Acta Paediatr. 81, 757-759
24. Piccioni, P.D., Kramps, J.A., Rudolphus, A., Bulgheroni, A. and Luisetti, M. (1992) Proteinase/proteinase inhibitor imbalance in sputum sol phases from patients with chronic obstructive pulmonary disease: suggestions for a key role played by antileukoprotease. Chest 102, 1470-1476
25. Willems, L.N., Otto-Verberne, C.J., Kramps, J.A., ten Have-Opbroek, A.A. and Dijkman, J.H. (1986) Detection of antileukoprotease in connective tissue of the lung. Histochemistry 86, 165-168 (Pubitemid 17025141)
26. Kramps, J.A., Te Boekhorst, A.H., Fransen, J.A., Ginsel, L.A. and Dijkman, J.H. (1989) Antileukoprotease is associated with elastin fibers in the extracellular matrix of the human lung: an immunoelectron microscopic study. Am. Rev. Respir. Dis. 140, 471-476 (Pubitemid 19218366)
27. Schill, W.B., Wallner, O., Schiessler, H. and Fritz, H. (1978) Immunofluorescent localization of the acid-stable proteinase inhibitor (antileukoprotease) of human cervical mucus. Experientia 34, 509-510 (Pubitemid 8306386)
28. Moriyama, A., Shimoya, K., Kawamoto, A., Hashimoto, K., Ogata, I., Kunishige, I., Ohashi, K., Azuma, C., Saji, F. and Murata, Y. (1998) Secretory leukocyte protease inhibitor (SLP) concentrations in seminal plasma: SLPI restores sperm motility reduced by elastase. Mol. Hum. Reprod. 4, 946-950 (Pubitemid 28475249)
29. Casslen, B., Rosengren, M. and Ohlsson, K. (1981) Localization and quantitation of a low molecular weight proteinase inhibitor, antileukoprotease, in the human uterus. Hoppe-Seyler's Z. Physiol. Chem. 362, 953-961 (Pubitemid 11009526)
30. Moriyama, A., Shimoya, K., Ogata, I., Kimura, T., Nakamura, T., Wada, H., Ohashi, K., Azuma, C., Saji, F. and Murata, Y. (1999) Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle. Mol. Hum. Reprod. 5, 656-661 (Pubitemid 29317756)
31. Helmig, R., Uldbjerg, N. and Ohlsson, K. (1995) Secretory leukocyte protease inhibitor in the cervical mucus and in the fetal membranes. Eur. J. Obstet. Gynecol. Reprod. Biol. 59, 95-101
32. Ohlsson, M., Fryksmark, U., Polling, A., Tegner, H. and Ohlsson, K. (1984) Localization of antileukoprotease in the parotid and the submandibular salivary glands. Acta Otolaryngol. 98, 147-151 (Pubitemid 14082006)
33. Shugars, D.C., Watkins, C.A. and Cowen, H.J. (2001) Salivary concentration of secretory leukocyte protease inhibitor, an antimicrobial protein, is decreased with advanced age. Gerontology 47, 246-253 (Pubitemid 32725028)
34. Cox, S.W., Rodriguez-Gonzalez, E.M., Booth, V. and Eley, B.M. (2006) Secretory leukocyte protease inhibitor and its potential interactions with elastase and cathepsin B in gingival crevicular fluid and saliva from patients with chronic periodontitis. J. Periodontal Res. 41, 477-485 (Pubitemid 44337263)
35. Carlsson, B. and Ohlsson, K. (1983) Localization of antileukoprotease in middle ear mucosa. Acta Otolaryngol. 95, 111-116 (Pubitemid 13206205)
36. Lee, J.K., Chae, S.W., Cho, J.G., Lee, H.M., Hwang, S.J. and Jung, H.H. (2006) Expression of secretory leukocyte protease inhibitor in middle ear cholesteatoma. Eur. Arch. Otorhinolaryngol. 263, 1077-1081
37. Fryksmark, U., Jannert, M., Ohlsson, K. and Tegner, H. (1985) Antileukoprotease in patients with maxillary sinusitis. Rhinology 23, 247-251 (Pubitemid 15239457)
38. Bergenfeldt, M., Nystrom, M., Bohe, M., Lindstrom, C., Polling, A. and Ohlsson, K. (1996) Localization of immunoreactive secretory leukocyte protease inhibitor (SLPI) in intestinal mucosa. J. Gastroenterol. 31, 18-23 (Pubitemid 26048467)
39. Nystrom, M., Westin, U.P., Linder, C. and Ohlsson, K. (2001) Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa. Mediators Inflammation 10, 269-272 (Pubitemid 33097154)
40. Wiedow, O., Young, J.A., Davison, M.D. and Christophers, E. (1993) Antileukoprotease in psoriatic scales. J. Invest. Dermatol. 101, 305-309 (Pubitemid 23269902)
41. 1-antitrypsin, and albumin in nasal secretions, by the method of unilateral antigen challenge. Allergy 54, 857-864
42. Shimoya, K., Moriyama, A., Ogata, I., Nobunaga, T., Koyama, M., Azuma, C. and Murata, Y. (2000) Increased concentrations of secretory leukocyte protease inhibitor in peritoneal fluid of women with endometriosis. Mol. Hum. Reprod. 6, 829-834 (Pubitemid 30660615)
43. Wex, T., Treiber, G., Nilius, M., Vieth, M., Roessner, A. and Malfertheiner, P. (2004) Helicobacter pylori-mediated gastritis induces local downregulation of secretory leukocyte protease inhibitor in the antrum. Infect. Immun. 72, 2383-2385 (Pubitemid 38419955)
44. 1-protease inhibitor and secretory leukocyte protease inhibitor levels in gingival crevicular fluid before and after non-surgical periodontal treatment. Oral Dis. 9, 249-254
45. Nielsen, K., Heegaard, S., Vorum, H., Birkenkamp-Demtroder, K., Ehlers, N. and Orntoft, T.F. (2005) Altered expression of CLC, DSG3, EMP3, S100A2, and SLPI in corneal epithelium from keratoconus patients. Cornea 24, 661-668 (Pubitemid 41060925)
46. Abbinante-Nissen, J.M., Simpson, L.G. and Leikauf, G.D. (1993) Neutrophil elastase increases secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am. J. Physiol. 265, L286-L292 (Pubitemid 23297392)
47. Sallenave, J.-M., Shulmann, J., Crossley, J., Jordana, M. and Gauldie, J. (1994) Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am. J. Respir. Cell Mol. Biol. 11, 733-741
48. Abbinante-Nissen, J.M., Simpson, L.G. and Leikauf, G.D. (1995) Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am. J. Physiol. 268, L601-L606
49. Velarde, M.C., Iruthayanathan, M., Eason, R.R., Zhang, D., Simmen, F.A. and Simmen, R.C. (2006) Progesterone receptor transactivation of the secretory leukocyte protease inhibitor gene in Ishikawa endometrial epithelial cells involves recruitment of Krüppel-like factor 9/basic transcription element binding protein-1. Endocrinology 147, 1969-1978
50. King, A.E., Morgan, K., Sallenave, J.-M. and Kelly, R.W. (2003) Differential regulation of secretory leukocyte protease inhibitor and elafin by progesterone. Biochem. Biophys. Res. Commun. 310, 594-599 (Pubitemid 37163706)
51. Williams, S.E., Brown, T.I., Roghanian, A. and Sallenave, J.-M. (2006) SLPI and elafin: one glove, many fingers. Clin. Sci. 110, 21-35 (Pubitemid 43059043)
52. Roghanian, A. and Sallenave, J.-M. (2008) Neutrophil elastase (NE) and NE inhibitors: canonical and noncanonical functions in lung chronic inflammatory diseases (cystic fibrosis and chronic obstructive pulmonary disease). J. Aerosol Med. Pulm. Drug Deliv. 21, 125-144
53. Sallenave, J.-M. (2010) Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity. Am. J. Respir. Cell Mol. Biol. 42, 635-643
54. Ashcroft, G.S., Lei, K., Jin, W., Longenecker, G., Kulkarni, A.B., Greenwell-Wild, T., Hale-Donze, H., McGrady, G., Song, X.Y. and Wahl, S.M. (2000) Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat. Med. 6, 1147-1153
55. Zhu, J., Nathan, C., Jin, W., Sim, D., Ashcroft, G.S., Wahl, S.M., Lacomis, L., Erdjument-Bromage, H., Tempst, P., Wright, C.D. and Ding, A. (2002) Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 111, 867-878 (Pubitemid 36106407)
56. Angelov, N., Moutsopoulos, N., Jeong, M.J., Nares, S., Ashcroft, G. and Wahl, S.M. (2004) Aberrant mucosal wound repair in the absence of secretory leukocyte protease inhibitor. Thromb. Haemostasis 92, 288-297 (Pubitemid 39172309)
57. Schneeberger, S., Hautz, T., Wahl, S.M., Brandacher, G., Sucher, R., Steinmassl, O., Steinmassl, P., Wright, C.D., Obrist, P., Werner, E.R. et al. (2008) The effect of secretory leukocyte protease inhibitor (SLPI) on ischemia/reperfusion injury in cardiac transplantation. Am. J. Transplant. 8, 773-782 (Pubitemid 351347766)
58. Jin, F.Y., Nathan, C., Radzioch, D. and Ding, A. (1997) Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 88, 417-426 (Pubitemid 27131383)
59. Jin, F., Nathan, C.F., Radzioch, D. and Ding, A. (1998) Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor. Infect. Immun. 66, 2447-2452 (Pubitemid 28261737)
60. Zhu, J., Nathan, C. and Ding, A. (1999) Suppression of macrophage responses to bacterial lipopolysaccharide by a non-secretory form of secretory leukocyte protease inhibitor. Biochim. Biophys. Acta 1451, 219-223 (Pubitemid 29518238)
61. Yang, J., Zhu, J., Sun, D. and Ding, A. (2005) Suppression of macrophage responses to bacterial lipopolysaccharide (LPS) by secretory leukocyte protease inhibitor (SLPI) is independent of its anti-protease function. Biochim. Biophys. Acta 1745, 310-317 (Pubitemid 41330785)
62. Mulligan, M.S., Lentsch, A.B., Huber-Lang, M., Guo, R.F., Sarma, V., Wright, C.D., Ulich, T.R. and Ward, P.A. (2000) Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor. Am. J. Pathol. 156, 1033-1039 (Pubitemid 30626961)
63. Wang, X., Li, X., Xu, L., Zhan, Y., Yaish-Ohad, S., Erhardt, J.A., Barone, F.C. and Feuerstein, G.Z. (2003) Up-regulation of secretory leukocyte protease inhibitor (SLPI) in the brain after ischemic stroke: adenoviral expression of SLPI protects brain from ischemic injury. Mol. Pharmacol. 64, 833-840 (Pubitemid 37153051)
64. Henriksen, P.A., Hitt, M., Xing, Z., Wang, J., Haslett, C., Riemersma, R.A., Webb, D.J., Kotelevtsev, Y.V. and Sallenave, J.-M. (2004) Adenoviral gene delivery of elafin and secretory leukocyte protease inhibitor attenuates NF-κB-dependent inflammatory responses of human endothelial cells and macrophages to atherogenic stimuli. J. Immunol. 172, 4535-4544 (Pubitemid 38375271)
65. Song, X., Zeng, L., Jin, W., Thompson, J., Mizel, D.E., Lei, K., Billinghurst, R.C., Poole, A.R. and Wahl, S.M. (1999) Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis. J. Exp. Med. 190, 535-542 (Pubitemid 29395381)
66. Lentsch, A.B., Yoshidome, H., Warner, R.L., Ward, P.A. and Edwards, M.J. (1999) Secretory leukocyte protease inhibitor in mice regulates local and remote organ inflammatory injury induced by hepatic ischemia/reperfusion. Gastroenterology 117, 953-961 (Pubitemid 29468239)
67. Wright, C.D., Havill, A.M., Middleton, S.C., Kashem, M.A., Lee, P.A., Dripps, D.J., O'Riordan, T.G., Bevilacqua, M.P. and Abraham, W.M. (1999) Secretory leukocyte protease inhibitor prevents allergen-induced pulmonary responses in animal models of asthma. J. Pharmacol. Exp. Ther. 289, 1007-1014 (Pubitemid 29191260)
68. Murata, E., Sharmin, S., Shiota, H., Shiota, M., Yano, M. and Kido, H. (2003) The effect of topically applied secretory leukocyte protease inhibitor on the eosinophil response in the late phase of allergic conjunctivitis. Curr. Eye Res. 26, 271-276 (Pubitemid 36876228)
69. Samsom, J.N., van der Marel, A.P., van Berkel, L.A., van Helvoort, J.M., Simons-Oosterhuis, Y., Jansen, W., Greuter, M., Nelissen, R.L., Meeuwisse, C.M., Nieuwenhuis, E.E. et al. (2007) Secretory leukoprotease inhibitor in mucosal lymph node dendritic cells regulates the threshold for mucosal tolerance. J. Immunol. 179, 6588-6595
70. Xu, W., He, B., Chiu, A., Chadburn, A., Shan, M., Buldys, M., Ding, A., Knowles, D.M., Santini, P.A. and Cerutti, A. (2007) Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI. Nat. Immunol. 8, 294-303 (Pubitemid 46745379)
71. Hochstrasser, K., Albrecht, G.J., Schonberger, O.L., Rasche, B. and Lempart, K. (1981) An elastase-specific inhibitor from human bronchial mucusIsolation and characterization. Hoppe-Seyler's Z. Physiol. Chem. 362, 1369-1375 (Pubitemid 12167425)
72. Kramps, J.A. and Klasen, E.C. (1985) Characterization of a low molecular weight anti-elastase isolated from human bronchial secretion. Exp. Lung Res. 9, 151-165 (Pubitemid 16207638)
73. Wiedow, O., Schroder, J.M., Gregory, H., Young, J.A. and Christophers, E. (1990) Elafin: an elastase-specific inhibitor of human skin. Purification, characterization and complete amino acid sequence. J. Biol. Chem. 265, 14791-14795
74. Sallenave, J.-M. and Ryle, A.P. (1991) Purification and characterization of elastase-specific inhibitor. Sequence homology with mucus proteinase inhibitor. Biol. Chem. Hoppe Seyler 372, 13-21
75. Sallenave, J.-M., Marsden, M.D. and Ryle, A.P. (1992) Isolation of elafin and elastase-specific inhibitor (ESI) from bronchial secretions: evidence of sequence homology and immunological cross-reactivity. Biol. Chem. Hoppe Seyler 373, 27-33
76. Saheki, T., Ito, F., Hagiwara, H., Saito, Y., Kuroki, J., Tachibana, S. and Hirose, S. (1992) Primary structure of the human elafin precursor preproelafin deduced from the nucleotide sequence of its gene and the presence of unique repetitive sequences in the prosegment. Biochem. Biophys. Res. Commun. 185, 240-245
77. Sallenave, J.-M. and Silva, A. (1993) Characterization and gene sequence of the precursor of elafin, an elastase-specific inhibitor in bronchial secretions. Am. J. Respir. Cell Mol. Biol. 8, 439-445
78. Nara, K., Ito, S., Ito, T., Suzuki, Y., Ghoneim, M.A., Tachibana, S. and Hirose, S. (1994) Elastase inhibitor elafin is a new type of proteinase inhibitor which has a transglutaminase-mediated anchoring sequence termed 'cementoin'. J. Biochem. 115, 441-448 (Pubitemid 24096454)
79. Bairoch, A. and Apweiler, R. (1997) The SWISS-PROT protein sequence database: its relevance to human molecular medical research. J. Mol. Med. 75, 312-316 (Pubitemid 27247962)
80. Tremblay, G.M., Vachon, E., Larouche, C. and Bourbonnais, Y. (2002) Inhibition of human neutrophil elastase-induced acute lung injury in hamsters by recombinant human pre-elafin (trappin-2). Chest 121, 582-588 (Pubitemid 34133001)
81. Motta, J.-P., Magne, L., Descamps, D., Rolland, C., Squarzoni-Dale, C., Rousset, P., Martin, L., Cenac, N., Balloy, V., Huerre, M. et al. (2011) Modifying the protease, antiprotease pattern by elafin overexpression protects mice from colitis. Gastroenterology 140, 1272-1282
82. Wehkamp, J., Schmid, M. and Stange, E.F. (2007) Defensins and other antimicrobial peptides in inflammatory bowel disease. Curr. Opin. Gastroenterol. 23, 370-378 (Pubitemid 46878947)
83. Schmid, M., Fellermann, K., Fritz, P., Wiedow, O., Stange, E.F. and Wehkamp, J. (2007) Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease. J. Leukocyte Biol. 81, 907-915 (Pubitemid 46495639)
84. Tanaka, N., Fujioka, A., Tajima, S., Ishibashi, A. and Hirose, S. (2000) Elafin is induced in epidermis in skin disorders with dermal neutrophilic infiltration: interleukin-1α and tumour necrosis factor-α stimulate its secretion in vitro. Br. J. Dermatol. 143, 728-732
85. Pfundt, R., van Vlijmen-Willems, I., Bergers, M., Wingens, M., Cloin, W. and Schalkwijk, J. (2001) In situ demonstration of phosphorylated c-jun and p38 MAP kinase in epidermal keratinocytes following ultraviolet B irradiation of human skin. J. Pathol. 193, 248-255 (Pubitemid 32118137)
86. Pfundt, R., Wingens, M., Bergers, M., Zweers, M., Frenken, M. and Schalkwijk, J. (2000) TNF-α and serum induce SKALP/elafin gene expression in human keratinocytes by a p38 MAP kinase-dependent pathway. Arch. Dermatol. Res. 292, 180-187 (Pubitemid 30237519)
87. Bingle, L., Tetley, T.D. and Bingle, C.D. (2001) Cytokine-mediated induction of the human elafin gene in pulmonary epithelial cells is regulated by nuclear factor-κB. Am. J. Respir. Cell Mol. Biol. 25, 84-91 (Pubitemid 32682709)
88. Reid, P.T., Marsden, M.E., Cunningham, G.A., Haslett, C. and Sallenave, J.-M. (1999) Human neutrophil elastase regulates the expression and secretion of elafin (elastase-specific inhibitor) in type II alveolar epithelial cells. FEBS Lett. 457, 33-37 (Pubitemid 29387404)
89. van Wetering, S., van der Linden, A.C., van Sterkenburg, M.A., De Boer, W.I., Kuijpers, A.L., Schalkwijk, J. and Hiemstra, P.S. (2000) Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins. Am. J. Physiol. Lung Cell. Mol. Physiol. 278, L51-L58 (Pubitemid 30104174)
90. Butler, M.W., Robertson, I., Greene, C.M., O'Neill, S.J., Taggart, C.C. and McElvaney, N.G. (2006) Elafin prevents lipopolysaccharide-induced AP-1 and NF-κB activation via an effect on the ubiquitin-proteasome pathway. J. Biol. Chem. 281, 34730-34735 (Pubitemid 46036512)
91. Simpson, A.J., Wallace, W.A., Marsden, M.E., Govan, J.R., Porteus, D.J., Haslett, C. and Sallenave, J.-M. (2001) Adenoviral augmentation of elafin protects the lung against acute injury mediated by activated neutrophils and bacterial infection. J. Immunol. 167, 1778-1786 (Pubitemid 32703182)
92. Simpson, A.J., Cunningham, G.A., Porteous, D.J., Haslett, C. and Sallenave, J.-M. (2001) Regulation of adenovirus-mediated elafin transgene expression by bacterial lipopolysaccharide. Hum. Gene Ther. 12, 1395-1406 (Pubitemid 32881345)
93. Sallenave, J.-M., Cunningham, G.A., James, R.M., McLachlan, G. and Haslett, C. (2003) Regulation of pulmonary and systemic bacterial lipopolysaccharide responses in transgenic mice expressing human elafin. Infect. Immun. 71, 3766-3774 (Pubitemid 36753697)
94. Roghanian, A., Williams, S.E., Sheldrake, T.A., Brown, T.I., Oberheim, K., Xing, Z., Howie, S.E. and Sallenave, J.-M. (2006) The antimicrobial/elastase inhibitor elafin regulates lung dendritic cells and adaptive immunity. Am. J. Respir. Cell Mol. Biol. 34, 634-642
95. Wilkinson, T.S., Dhaliwal, K., Hamilton, T.W., Lipka, A.F., Farrell, L., Davidson, D.J., Duffin, R., Morris, A.C., Haslett, C., Govan, J.R. et al. (2009) Trappin-2 promotes early clearance of Pseudomonas aeruginosa through CD14-dependent macrophage activation and neutrophil recruitment. Am. J. Pathol. 174, 1338-1346
96. McMichael, J.W., Roghanian, A., Jiang, L., Ramage, R. and Sallenave, J.-M. (2005) The antimicrobial antiproteinase elafin binds to lipopolysaccharide and modulates macrophage responses. Am. J. Respir. Cell Mol. Biol. 32, 443-452 (Pubitemid 40629330)
97. Tremblay, G.M., Sallenave, J.-M., Israel-Assayag, E., Cormier, Y. and Gauldie, J. (1996) Elafin/elastase-specific inhibitor in bronchoalveolar lavage of normal subjects and farmer's lung. Am. J. Respir. Crit. Care Med. 154, 1092-1098
98. Schalkwijk, J., van Vlijmen, I.M., Alkemade, J.A. and De Jongh, G.J. (1993) Immunohistochemical localization of SKALP/elafin in psoriatic epidermis. J. Invest. Dermatol. 100, 390-393 (Pubitemid 23105202)
99. Kabelitz, D., Glatzel, A. and Wesch, D. (2000) Antigen recognition by human γδ T lymphocytes. Int. Arch. Allergy Immunol. 122, 1-7
100. Hayday, A.C. (2000) ã ä cells: a right time and a right place for a conserved third way of protection. Annu. Rev. Immunol. 18, 975-1026
101. Brandes, M., Willimann, K. and Moser, B. (2005) Professional antigen-presentation function by human γδ T cells. Science 309, 264-268 (Pubitemid 40967855)
102. Dieli, F., Troye-Blomberg, M., Ivanyi, J., Fournie, J.J., Krensky, A.M., Bonneville, M., Peyrat, M.A., Caccamo, N., Sireci, G. and Salerno, A. (2001) Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vγ9/Vδ2 T lymphocytes. J. Infect. Dis. 184, 1082-1085 (Pubitemid 32955129)
103. Agerberth, B., Charo, J., Werr, J., Olsson, B., Idali, F., Lindbom, L., Kiessling, R., Jornvall, H., Wigzell, H. and Gudmundsson, G.H. (2000) The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96, 3086-3093
104. Selsted, M.E. and Ouellette, A.J. (2005) Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 6, 551-557 (Pubitemid 41710724)